Accueil > Actualité
Actualite financiere : Actualite bourse

AstraZeneca: EU approves third dose of Vaxzevria

( - AstraZeneca says that its Covid-19 vaccine, Vaxzevria, has been approved in the European Union (EU) by the European Medicines Agency (EMA) as a third-dose booster in adults.

Healthcare professionals can now use the product as a third-dose booster in patients who have already received a primary vaccination regimen of Vaxzevria or an EU-approved Covid-19 mRNA vaccine.

This authorisation is based on evidence demonstrating an enhanced immune response after a third booster dose with Vaxzevria following a primary vaccination schedule of Vaxzevria or an mRNA vaccine.

AstraZeneca said that Vaxzevria is estimated to have helped prevent 50 million cases of Covid-19, five million hospitalisations and saved over one million lives worldwide, based on model results evaluating Covid-19 worldwide.

Copyright (c) 2022 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.